Junlian Capital leads the near 100 million yuan A+ round financing of Huixinbiotech.

On February 9, Shenzhen Huixin Biomedical Technology Co., Ltd. announced the completion of a nearly hundred million yuan Series A+ financing round, led by Junlian Capital.